Northern Trust’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $117K | Sell |
72,417
-74,605
| -51% | -$121K | ﹤0.01% | 4079 |
|
|
2025
Q1 | $105K | Sell |
147,022
-10,595
| -7% | -$7.6K | ﹤0.01% | 4102 |
|
|
2024
Q4 | $175K | Buy |
157,617
+44,252
| +39% | +$49.1K | ﹤0.01% | 4027 |
|
|
2024
Q3 | $79.4K | Sell |
113,365
-267,378
| -70% | -$187K | ﹤0.01% | 4111 |
|
|
2024
Q2 | $381K | Sell |
380,743
-17,619
| -4% | -$17.6K | ﹤0.01% | 3609 |
|
|
2024
Q1 | $944K | Buy |
398,362
+1,141
| +0.3% | +$2.7K | ﹤0.01% | 3331 |
|
|
2023
Q4 | $894K | Buy |
397,221
+45,780
| +13% | +$103K | ﹤0.01% | 3349 |
|
|
2023
Q3 | $745K | Buy |
351,441
+687
| +0.2% | +$1.46K | ﹤0.01% | 3388 |
|
|
2023
Q2 | $1.08M | Buy |
350,754
+283,118
| +419% | +$875K | ﹤0.01% | 3328 |
|
|
2023
Q1 | $364K | Buy |
67,636
+30,861
| +84% | +$166K | ﹤0.01% | 3584 |
|
|
2022
Q4 | $245K | Buy |
36,775
+13,653
| +59% | +$90.8K | ﹤0.01% | 3775 |
|
|
2022
Q3 | $92K | Buy |
23,122
+4,096
| +22% | +$16.3K | ﹤0.01% | 4140 |
|
|
2022
Q2 | $94K | Sell |
19,026
-125,941
| -87% | -$622K | ﹤0.01% | 4196 |
|
|
2022
Q1 | $875K | Sell |
144,967
-6,959
| -5% | -$42K | ﹤0.01% | 3482 |
|
|
2021
Q4 | $1.77M | Sell |
151,926
-1,125
| -0.7% | -$13.1K | ﹤0.01% | 3282 |
|
|
2021
Q3 | $2.4M | Buy |
153,051
+42,073
| +38% | +$660K | ﹤0.01% | 3189 |
|
|
2021
Q2 | $2.07M | Sell |
110,978
-10,976
| -9% | -$205K | ﹤0.01% | 3339 |
|
|
2021
Q1 | $5.26M | Buy |
+121,954
| New | +$5.26M | ﹤0.01% | 2715 |
|